Cargando…
Deformation-based morphometry identifies deep brain structures protected by ocrelizumab
BACKGROUND: Despite advancements in treatments for multiple sclerosis, insidious disease progression remains an area of unmet medical need, for which atrophy-based biomarkers may help better characterize the progressive biology. METHODS: We developed and applied a method of longitudinal deformation-...
Autores principales: | Song, Zhuang, Krishnan, Anithapriya, Gaetano, Laura, Tustison, Nicholas J., Clayton, David, de Crespigny, Alex, Bengtsson, Thomas, Jia, Xiaoming, Carano, Richard A.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861820/ https://www.ncbi.nlm.nih.gov/pubmed/35189455 http://dx.doi.org/10.1016/j.nicl.2022.102959 |
Ejemplares similares
-
Multi-arm U-Net with dense input and skip connectivity for T2 lesion segmentation in clinical trials of multiple sclerosis
por: Krishnan, Anitha Priya, et al.
Publicado: (2023) -
Deformation based morphometry study of longitudinal MRI changes in behavioral variant frontotemporal dementia
por: Manera, Ana L., et al.
Publicado: (2019) -
Heart and bladder detection and segmentation on FDG PET/CT by deep learning
por: Wang, Xiaoyong, et al.
Publicado: (2022) -
Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry
por: Hallin, Erik I., et al.
Publicado: (2022) -
Tumor Segmentation and Feature Extraction from Whole-Body FDG-PET/CT Using Cascaded 2D and 3D Convolutional Neural Networks
por: Jemaa, Skander, et al.
Publicado: (2020)